Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT02349412What this trial is testingEarly Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversWho this might be right forLiver CancerAnxiety DisorderDepression+7 more Alliance for Clinical Trials in Oncology 405
Not applicableUnknownNCT03210298What this trial is testingInternational Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)Who this might be right forPeritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more Sabine Rhode 1,000
Testing effectiveness (Phase 2)Ended earlyNCT05070247What this trial is testingTAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerHepatocellular CancerMesothelioma+7 more Takeda 61
Testing effectiveness (Phase 2)WithdrawnNCT06090318What this trial is testingMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossWho this might be right forAdvanced Solid TumorCDKN2ANSCLC+7 more Rain Oncology Inc
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Study completedNCT01411189What this trial is testingPhase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal EndoscopyWho this might be right forGastric CancerColon Nos Polypectomy Tubular AdenomaGastric Adenoma Nihon Pharmaceutical Co., Ltd 33
Early research (Phase 1)UnknownNCT05415098What this trial is testingStudy of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasWho this might be right forNasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more Ascentage Pharma Group Inc. 90
Not applicableLooking for participantsNCT06822413What this trial is testingRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisWho this might be right forCancer DiagnosisLiver Cancer, AdultCancer Screening+14 more Second Affiliated Hospital, School of Medicine, Zhejiang University 600
Post-approval studies (Phase 4)Study completedNCT02638584What this trial is testingEffects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.Who this might be right forGastric Cancer Il-Yang Pharm. Co., Ltd. 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Not applicableStudy completedNCT01813994What this trial is testingRole of Statin on the Gastric Inflammation in Patients at High Risk of Gastric CancerWho this might be right forEarly Gastric Cancer or Gastric Adenoma Yonsei University 96
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Not applicableStudy completedNCT04602689What this trial is testingFibrin Glue After ESD for High Risk Patients of BleedingWho this might be right forEarly Gastric CancerGastric Adenoma Seoul National University Hospital 134
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15